REFERENCES
- Teke K, Kisa A, Demir C, Ersoy K. Appropriateness of admission and length of stay in a Turkish Military Hospital. Journal of Medical System 2004; 28(6)653–63
- Kisa A. An Analysis of the Pharmaceuticals Market in Turkey. Proceedings of Third International Healthcare Conference, Chandra Ashish. 2004
- Kisa A. The Economic Dimensions of the Non-Adherence to Long Term Therapies. American Business and Health Administration Proceedings Book, Bleidt Barry, Tipton David. Midwest Business Administration Association, Chicago, IL 2003
- Kisa A. The Performance of The Turkish Pharmaceutical Industry. American Business and Health Administration Proceedings Book, Donna Reddings, Ashish Chandra. Midwest Business Administration Association, Chicago, IL 2001
- Carthy P, Harvey I, Brawn R, Watkins C. A study of factors associated with cost and variation in prescribing among GPs. Family Practice 2000; 17(1)36–41
- Greenfield S, Bryan S, Gill P, Gutridge K, Marshall T. Factors influencing clinicians' decisions to prescribe medication to prevent coronary heart disease. Journal of Clinical Pharmacy and Therapeutics 2005; 30(1)77–84
- Szecsenyi J. Influence of attitudes and behaviour of GPs on prescribing costs. Quality and Safety in Health Care 2003; 12(1)6–7
- Naylor CD. The Complex World of Prescribing Behavior. JAMA 2004; 291(1)104–6
- Westfall JM. Physicians, Pharmaceutical Representatives, and Patients: Who Really Benefits?. Journal of Family Practice 2000; 49: 817–19
- Scotson JH. The ethics of prescribing drugs. Ethics and Medicine 1988; 4(3)44–6
- Pitaknetinan K, Tangcharoensathien V, Supachutikul A, Bennett S, Mills A. Profit, payment and pharmaceutical practices: perspectives from hospitals in Bangkok. Health Policy 1999; 46(3)179–94
- Schumock GT, Walton SM, Park HY, Nutescu EA, Blackburn JC, Finley JM, Lewis RK. Factors that influence prescribing decisions. The Annals of Pharmacotherapy 2004; 38(4)557–62
- Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift?. JAMA 2000; 19; 283(3)373–80
- Tengilimoglu D, Kisa A, Ekiyor A. The pharmaceutical sales rep/physician relationship in Turkey: ethical issues in an international context. Health Marketing Quarterly 2004; 22(1)21–39
- Madhavan S, Amonkar MM, Elliott D, Burke K, Gore P. The gift relationship between pharmaceutical companies and physicians: an exploratory survey of physicians. Journal of Clinical Pharmacy and Therapeutics 1997; 22(3)207–15
- Mason J, Freemantle N, Nazareth I, Eccles M, Haines A, Drummond M. When is it cost-effective to change the behavior of health professionals?. JAMA 2001; 19; 286(23)2988–92
- Cutts C, Tett SE. Influences on doctors' prescribing: Is geographical remoteness a factor?. Australian Journal of Rural Health 2003; 11: 124–30
- Cockburn J, Pitt S. Prescribing behaviour in clinical practice:patients' expectations and doctors' perception of patients' expectations– a questionnaire study. British Medical Journal 1997; 315: 520–23
- Caudill TS, Lurie N, Rich EC. The influence of pharmaceutical industry advertising on physician prescribing. Journal of Drug Issues 1992; 22: 331–38
- Frazier LM, Brown T, Divine GW, Fleming GR, Philips NM, Siegal WC, Khayrallah MA. Can physician education lower the cost of prescrition drugs?. Annals of Internal Medicine 1991; 115: 116–21